Fortress Biotech, Inc. (FBIOP) Raw Materials (2021 - 2025)
Fortress Biotech (FBIOP) posted quarterly Raw Materials of $2.8 million for Q1 2025, down 32.82% year-over-year from $4.2 million in Q1 2024, and down 12.14% quarter-over-quarter from $3.2 million in Q4 2024.
Fortress Biotech, Inc. (FBIOP) Raw Materials (2021 - 2025) Analysis & Trends
Fortress Biotech's Raw Materials history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2025.
- In Q1 2025, Raw Materials fell 32.82% year-over-year to $2.8 million; the TTM figure through Mar 2025 stood at $2.8 million (down 32.82% YoY), while the FY2024 annual figure was $3.2 million, down 31.12% from the prior year.
- Raw Materials for Q1 2025 stood at $2.8 million, down from $3.2 million in the prior quarter.
- The five-year high for Raw Materials was $8.4 million in Q1 2022, with the low at $2.8 million in Q1 2025.
- The 5-year median for Raw Materials is $5.1 million (2021), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2023: Raw Materials jumped 46.89% in 2022, then tumbled 34.53% in 2023.
- Fortress Biotech's Raw Materials stood at $5.6 million in 2021, then climbed by 15.83% to $6.5 million in 2022, then slipped by 28.11% to $4.6 million in 2023, then sank by 31.12% to $3.2 million in 2024, then declined by 12.14% to $2.8 million in 2025.
- Business Quant data shows FBIOP's Raw Materials at $2.8 million in Q1 2025, $3.2 million in Q4 2024, and $3.6 million in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.81 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 5.26 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 6.45 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 7.21 Mn |
| Mar 31, 2022 | 8.36 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 5.45 Mn |
| Jun 30, 2021 | 4.91 Mn |